No Data
No Data
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Neurogene and Ventyx Biosciences Rises After Insider Buying by Executives
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Neurogene CEO Rachel McMinn Acquires $968,999 in Stock
Insider Purchase: President and CFO of $NGNE (NGNE) Buys 24,000 Shares
H.C. Wainwright Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $55